Derived from the STOXX Developed Markets Total Market Index, the iSTOXX Developed Markets B.R.AI.N. Index is comprised of companies that are exposed to four megatrends that are expected to change the world as we know it: biotechnology (B), robotics (R), artificial intelligence (AI) and nanotechnology (N). Revere (RBICS) data allow a detailed breakdown of the revenue sources of the eligible companies, helping this index to select companies with substantial exposure to the B.R.AI.N. themes.
Index Guides, Benchmark statement, and other reports are available under the Data tab.
Top 10 Components
|Eli Lilly & Co.||Health Care||US|
|NOVO NORDISK B||Health Care||DK|
|Bristol-Myers Squibb Co.||Health Care||US|
|Amgen Inc.||Health Care||US|
|Gilead Sciences Inc.||Health Care||US|
|CSL Ltd.||Health Care||AU|
|ADVANCED MICRO DEVICES||Technology||US|
Stocks rebound in October on hopes for Fed’s policy pivot
The STOXX Global 1800 index rose 7.1% in dollars last month, after falling to a two-year low. While most economists rightly forecast the Federal Reserve’s fourth consecutive hike of 75 basis points on Nov. 2, speculation grew during October that the central bank could indicate it would slow the pace of monetary tightening.
Stocks rebound in March on hopes of Ukraine conflict resolution
The STOXX Global 1800 index rose 2.7% in dollars last month, with basic-resources and energy companies leading gains for a second consecutive month. The benchmark is still down 5.5% for 2022.